Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Global Liquid Biopsy Market 2019 Analysis by Biomarkers, Cancer Type, Regions, Key Profiles and Forecasts to 2024 Report by ReportsnReports

According to research report, the Liquid Biopsy Market was valued at USD 899.55 million for the year 2018


News provided by

ReportsnReports

30 Oct, 2019, 12:00 GMT

Share this article

Share toX

Share this article

Share toX

PUNE, India, Oct. 30, 2019 /PRNewswire/ -- Over the recent years, Liquid Biopsy has been witnessing considerable growth on the back of growing focus on immunotherapy to cure cancer and shifting trend towards precision medicine along with high per capita healthcare expenditure and rapid adoption of novel diagnostic test by oncologist. Further, rising awareness for the early detection of cancer and sharp rise in its incidences have contributed to the growth rate of Liquid Biopsy Market. 

Company Analysis –

  • Roche Diagnostics,
  • Thermo Fisher Scientific,
  • Guardant Health,
  • Qiagen

Among the Circulating Biomarker, Ct- DNA is the most used biomarker for the diagnosis in pre and post cancerous stage, as it provides more comprehensive overview of the tumor genomic status. Ongoing research and clinical trials suggest that exosomes and nucleosomes, will provide more efficient diagnostic results and hence market will be growing in the forecast period.

Get Discount on Global Liquid Biopsy Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=2651119 

In the forecast period, continuous research and development by private manufacturers, government organizations and designated government labs along with growing number of clinical trials in liquid biopsy is anticipated to provide momentum to the market growth. However, generation of revenue from the liquid biopsy is dependent upon the interest of third-party payers, hindering the market growth.

Scope of the Report:

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Liquid Biopsy Market. The report analyses the Global Liquid Biopsy Market By Cancer Type (Lung, Breast, Colorectal, Prostate, Others), By Circulating Biomarker (Circulating tumor cells, ct-DNA, Vesicles) and By Product Type (Reagent, Instruments). The report analyzes the liquid biopsy market By Region (North America, Europe, APAC, ROW) and By Country (US, Germany, France, Japan) for the historical period of 2017 and 2018 and the forecast period of 2019-2024. 

Global Liquid Biopsy Market (Actual Period: 2017-2018, Forecast Period: 2019-2024)

  • Liquid Biopsy Market: Size, Growth, Forecast
  • Analysis By Cancer Type: Lung, Breast, Colorectal, Prostate, Others
  • Analysis By Circulating Biomarker: CTC, ct-DNA, Vesicles
  • Analysis By Product Type: Reagents, Instruments

For More Details Inquire on this Research Report at https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=2651119 

Regional Liquid Biopsy Market - North America, Europe, APAC, ROW (Actual Period: 2017-2018, Forecast Period: 2019-2024)

  • Liquid Biopsy Market: Size, Growth, Forecast
  • Analysis By Cancer Type: Lung, Breast, Colorectal, Prostate, Others
  • Analysis By Circulating Biomarker: CTC, ct-DNA, Vesicles
  • Analysis By Product Type: Reagents, Instruments

Country Analysis – U.S., Germany, France, Japan (Actual Period: 2017-2018, Forecast Period: 2019-2024)

  • Liquid Biopsy Market: Size, Growth, Forecast
  • Analysis By Cancer Type: Lung, Breast, Colorectal, Prostate, Others
  • Analysis By Circulating Biomarker: CTC, ct-DNA, Vesicles
  • Analysis By Product Type: Reagents, Instruments

Other Report Highlights

  • Competitive Landscape
  • Leading Companies
  • Investment and Partnerships
  • Product Analysis
  • Market Dynamics – Drivers and Restraints.
  • Market Trends
  • Porter Five Forces Analysis.
  • SWOT Analysis.
  • Company Analysis – Roche Diagnostics, Thermo Fisher Scientific, Guardant Health, Qiagen. 

Direct Purchase of Global Liquid Biopsy Market 2019-2024 Research Report at https://www.reportsnreports.com/purchase.aspx?name=2651119 

Table of Contents:

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Liquid Biopsy Market: Product Outlook

5. Global Liquid Biopsy Market: Growth and Forecast (2017-2024)

6. Global Liquid Biopsy Market: Segment Analysis

7. Global Liquid Biopsy Market: Regional Analysis

8. Global Liquid Biopsy Market: Competitive Landscape 

9. Global Liquid Biopsy Market Dynamics

10. Porter's Five Forces Analysis

11. SWOT Analysis

12. Policy and Regulatory Landscape

13. Company Profiles

Another Related Research Titled Global Breast Cancer Liquid Biopsy Market Report 2019 - Market Size, Share, Price, Trend and Forecast report is a professional and in-depth study on the current state of the global Breast Cancer Liquid Biopsy industry. The report provides key statistics on the market status of the Breast Cancer Liquid Biopsy manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. The report includes global key players of Breast Cancer Liquid Biopsy as well as some small players: QIAGEN, Roche Diagnostics, Bio-Rad Laboratories, Myriad Genetics, Menarini Silicon Biosystems, Genomic Health and others

For complete companies list, please ask for sample pages at https://www.reportsnreports.com/contacts/requestsample.aspx?name=2519005 

 About Us: 

ReportsnReports.com is your single source for all market research needs. Our database includes 100,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports. We provide 24/7 online and offline support to our customers.

Contact: 

Vishal Kalra
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India
+1-888-391-5441
sales@reportsandreports.com

Connect With Us on: 
Facebook: https://www.facebook.com/ReportsnReports/ 
LinkedIn: https://www.linkedin.com/company/reportsnreports 
Twitter: https://twitter.com/marketsreports 
RSS/Feeds: http://www.reportsnreports.com/feed/l-latestreports.xml

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.